Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.85%

Insider Buying (Last 12 Months): $15,270,038.49

Insider Selling (Last 12 Months): $16,830,836.65

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$35.51

▲ +0.74 (2.13%)

As of 11/6/2024 05:00 PM ET

Days: 30 | 90 | 365

The centerpiece of Trump’s crypto’s masterplan …

From Weiss Ratings | Ad

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Click here to find out more about what could be Trump and JD Vance’s favorite coin.

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730
8/30/2023	Dana Aftab	EVP	Sell	4,600	$22.47	$103,362.00	399,943
8/3/2023	Christopher J Senner	CFO	Sell	60,000	$20.51	$1,230,600.00	571,631
8/3/2023	Patrick J Haley	EVP	Sell	30,553	$20.67	$631,530.51	285,467
8/1/2023	Jeffrey J. Hessekiel	EVP	Sell	55,710	$19.63	$1,093,587.30	571,976
4/5/2023	Jeffrey J. Hessekiel	EVP	Sell	38,930	$20.01	$778,989.30	582,435
3/10/2023	Jack L Wyszomierski	Director	Sell	15,300	$16.61	$254,133.00	317,467
3/1/2023	Jeffrey J. Hessekiel	EVP	Sell	77,860	$17.13	$1,333,741.80	527,716
2/27/2023	Dana Aftab	EVP	Sell	10	$17.50	$175.00	351,472
2/21/2023	Alan M. Garber	Director	Sell	40,000	$17.49	$699,600.00	31,417
2/9/2023	Carl B. Feldbaum	Director	Sell	40,000	$17.78	$711,200.00	18,701
2/6/2023	Patrick J Haley	EVP	Sell	25,000	$17.37	$434,250.00	254,414
12/15/2022	Peter Lamb	EVP	Sell	20,000	$15.88	$317,600.00	410,958
11/29/2022	George Poste	Director	Sell	40,000	$16.68	$667,200.00	193,189
9/12/2022	Patrick J Haley	EVP	Sell	40,000	$17.94	$717,600.00	261,591
5/27/2022	Patrick J Haley	EVP	Sell	18,812	$18.21	$342,566.52	239,818
5/17/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$25.39	$457,020.00	604,822
5/12/2022	Lance Willsey	Director	Sell	40,000	$19.65	$786,000.00	424,415
4/4/2022	Jack L Wyszomierski	Director	Sell	6,696	$23.00	$154,008.00	273,192
3/31/2022	Patrick J Haley	EVP	Sell	10,000	$22.43	$224,300.00	269,191
3/28/2022	Jeffrey J. Hessekiel	EVP	Sell	4,717	$22.00	$103,774.00
3/1/2022	Alan M. Garber	Director	Sell	21,301	$21.00	$447,321.00
2/24/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$20.00	$360,000.00
2/22/2022	Stelios Papadopoulos	Director	Sell	84,515	$19.56	$1,653,113.40
2/3/2022	Patrick J Haley	EVP	Sell	60,000	$17.91	$1,074,600.00
12/15/2021	Peter Lamb	EVP	Sell	47,500	$17.44	$828,400.00
11/24/2021	Patrick J Haley	EVP	Sell	17,236	$17.25	$297,321.00
11/19/2021	Carl B. Feldbaum	Director	Sell	20,000	$17.62	$352,400.00
11/15/2021	Peter Lamb	EVP	Sell	47,500	$18.09	$859,275.00

The centerpiece of Trump’s crypto’s masterplan …

From Weiss Ratings | Ad

Click here to find out more about what could be Trump and JD Vance’s favorite coin.

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/6/2024	Cornercap Investment Counsel Inc.	24,903	$0.65M	0.2%	-50.7%	0.009%
11/6/2024	CIBC Asset Management Inc	8,758	$0.23M	0.0%	N/A	0.003%
11/6/2024	Sargent Investment Group LLC	232,245	$6.03M	1.1%	-4.4%	0.081%
11/5/2024	Buck Wealth Strategies LLC	8,500	$0.22M	0.1%	N/A	0.003%
11/5/2024	Victory Capital Management Inc.	136,178	$3.53M	0.0%	+16.6%	0.048%
11/5/2024	GSA Capital Partners LLP	11,708	$0.30M	0.0%	-81.9%	0.004%
11/5/2024	Entropy Technologies LP	18,300	$0.48M	0.0%	N/A	0.006%
11/4/2024	Los Angeles Capital Management LLC	1,790,855	$46.47M	0.2%	+124.0%	0.627%
11/4/2024	State of New Jersey Common Pension Fund D	107,585	$2.79M	0.0%	-3.5%	0.038%
11/4/2024	Meritage Portfolio Management	413,586	$10.73M	0.7%	-0.1%	0.145%
11/2/2024	Costello Asset Management INC	1,520	$39K	0.0%	-46.1%	0.001%
11/2/2024	Covestor Ltd	6,335	$0.16M	0.1%	+5.7%	0.002%
11/1/2024	CWA Asset Management Group LLC	22,222	$0.58M	0.0%	N/A	0.008%
11/1/2024	Capital Performance Advisors LLP	2,358	$61K	0.0%	N/A	0.001%
11/1/2024	Summit Global Investments	25,583	$0.66M	0.0%	-24.9%	0.009%
10/31/2024	Principal Financial Group Inc.	665,742	$17.28M	0.0%	-31.6%	0.233%
10/30/2024	Heritage Investors Management Corp	7,728	$0.20M	0.0%	N/A	0.003%
10/30/2024	Capital Management Corp VA	365,270	$9.48M	1.7%	+7.5%	0.128%
10/30/2024	Amalgamated Bank	139,712	$3.63M	0.0%	-6.9%	0.049%
10/30/2024	QRG Capital Management Inc.	54,879	$1.42M	0.0%	+6.4%	0.019%
10/29/2024	Robeco Institutional Asset Management B.V.	483,064	$12.54M	0.0%	+263.1%	0.169%
10/29/2024	Fort L.P.	8,680	$0.23M	0.6%	N/A	0.003%
10/29/2024	Van ECK Associates Corp	173,584	$4.92M	0.0%	+66.2%	0.061%
10/29/2024	Janney Montgomery Scott LLC	30,399	$0.79M	0.0%	-48.3%	0.011%
10/29/2024	Janney Capital Management LLC	13,521	$0.35M	0.0%	-3.9%	0.005%
10/29/2024	Farther Finance Advisors LLC	3,940	$0.10M	0.0%	+467.7%	0.001%
10/28/2024	Stephens Inc. AR	9,689	$0.25M	0.0%	N/A	0.003%
10/28/2024	Stephens Investment Management Group LLC	3,806,564	$98.78M	1.3%	-1.9%	1.334%
10/28/2024	Rice Hall James & Associates LLC	20,766	$0.54M	0.0%	-3.0%	0.007%
10/28/2024	US Bancorp DE	48,110	$1.25M	0.0%	-2.1%	0.017%
10/25/2024	First Trust Direct Indexing L.P.	15,532	$0.40M	0.0%	+30.6%	0.005%
10/25/2024	New York State Teachers Retirement System	439,222	$11.40M	0.0%	+4.8%	0.145%
10/25/2024	China Universal Asset Management Co. Ltd.	54,863	$1.42M	0.2%	+60.3%	0.018%
10/25/2024	abrdn plc	314,537	$8.16M	0.0%	-43.6%	0.104%
10/25/2024	Pallas Capital Advisors LLC	8,755	$0.25M	0.0%	N/A	0.003%
10/24/2024	State of Alaska Department of Revenue	126,842	$3.29M	0.0%	+1.2%	0.042%
10/24/2024	DekaBank Deutsche Girozentrale	429,690	$11.03M	0.0%	+7.5%	0.142%
10/24/2024	Wealth Enhancement Advisory Services LLC	143,547	$3.73M	0.0%	+4.6%	0.047%
10/24/2024	NorthCrest Asset Manangement LLC	11,778	$0.31M	0.0%	+12.5%	0.004%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	10,317	$0.27M	0.0%	+18.6%	0.003%
10/23/2024	Louisiana State Employees Retirement System	79,100	$2.05M	0.0%	-4.0%	0.026%
10/23/2024	Assenagon Asset Management S.A.	1,111,358	$28.84M	0.1%	-34.6%	0.367%
10/23/2024	Hennion & Walsh Asset Management Inc.	62,911	$1.63M	0.1%	-8.8%	0.021%
10/22/2024	Lecap Asset Management Ltd.	12,553	$0.33M	0.1%	N/A	0.004%
10/22/2024	Signaturefd LLC	6,138	$0.16M	0.0%	+12.2%	0.002%
10/19/2024	Allspring Global Investments Holdings LLC	858,004	$22.27M	0.0%	-24.6%	0.283%
10/18/2024	Raymond James & Associates	239,661	$6.22M	0.0%	+118.2%	0.079%
10/18/2024	Friedenthal Financial	28,674	$0.74M	0.4%	N/A	0.009%
10/18/2024	Blue Trust Inc.	6,094	$0.16M	0.0%	+54.2%	0.002%
10/17/2024	Inspire Advisors LLC	25,207	$0.65M	0.1%	+24.9%	0.008%
10/17/2024	V Square Quantitative Management LLC	1,138	$30K	0.0%	N/A	0.000%
10/16/2024	Kapitalo Investimentos Ltda	20,134	$0.52M	0.1%	N/A	0.007%
10/11/2024	Creative Planning	70,934	$1.84M	0.0%	-1.1%	0.025%
10/10/2024	Essex Investment Management Co. LLC	2,859	$74K	0.0%	N/A	0.001%
10/10/2024	Exchange Traded Concepts LLC	40,218	$1.04M	0.0%	-5.9%	0.013%
10/10/2024	Inspire Investing LLC	29,328	$0.76M	0.1%	+85.1%	0.010%
10/8/2024	CWM LLC	34,643	$0.90M	0.0%	+73.3%	0.011%
10/7/2024	Diversified Trust Co	19,234	$0.50M	0.0%	+40.3%	0.006%
10/7/2024	Meditor Group Ltd	1,362,450	$35.36M	73.4%	-22.3%	0.449%
10/7/2024	GAMMA Investing LLC	3,010	$78K	0.0%	+50.0%	0.001%
10/5/2024	Handelsbanken Fonder AB	78,466	$2.04M	0.0%	+28.1%	0.026%
10/3/2024	SG Americas Securities LLC	19,001	$0.49M	0.0%	-12.6%	0.006%
9/5/2024	Sanctuary Advisors LLC	27,504	$0.65M	0.0%	N/A	0.010%
8/21/2024	Truist Financial Corp	11,813	$0.27M	0.0%	-79.3%	0.004%
8/16/2024	Capital Impact Advisors LLC	34,104	$0.77M	2.2%	-20.5%	0.011%
8/16/2024	Systematic Financial Management LP	1,090,792	$24.51M	0.7%	-3.6%	0.360%
8/16/2024	Creative Planning	71,700	$1.61M	0.0%	+0.8%	0.024%
8/16/2024	Algert Global LLC	276,352	$6.21M	0.2%	+7.6%	0.091%
8/15/2024	Peloton Wealth Strategists	47,830	$1.08M	0.4%	-2.0%	0.016%
8/15/2024	Susquehanna Fundamental Investments LLC	241,874	$5.44M	0.1%	-47.4%	0.080%
8/15/2024	Mackenzie Financial Corp	433,311	$9.74M	0.0%	+62.1%	0.143%
8/15/2024	The Manufacturers Life Insurance Company	253,842	$5.70M	0.0%	-25.9%	0.084%
8/15/2024	Dark Forest Capital Management LP	13,212	$0.30M	0.1%	-27.2%	0.004%
8/15/2024	Deerfield Management Company L.P. Series C	20,816	$0.47M	0.0%	+137.1%	0.007%
8/15/2024	AQR Capital Management LLC	3,281,578	$73.43M	0.1%	+12.7%	1.082%
8/15/2024	AXA S.A.	291,415	$6.55M	0.0%	-30.0%	0.096%
8/15/2024	Caxton Associates LP	72,953	$1.64M	0.1%	-47.5%	0.024%
8/14/2024	Squarepoint Ops LLC	89,449	$2.01M	0.0%	+242.8%	0.030%
8/14/2024	Marshall Wace LLP	35,644	$0.80M	0.0%	N/A	0.012%
8/14/2024	Farallon Capital Management LLC	27,102,500	$608.99M	2.9%	+1.6%	8.939%
8/14/2024	Xponance Inc.	59,484	$1.34M	0.0%	-5.2%	0.020%
8/14/2024	Bank of Montreal Can	68,889	$1.55M	0.0%	-41.0%	0.023%
8/14/2024	DRW Securities LLC	17,425	$0.39M	0.0%	N/A	0.006%
8/14/2024	EverSource Wealth Advisors LLC	2,227	$52K	0.0%	-16.1%	0.001%
8/14/2024	Heron Bay Capital Management	65,269	$1.47M	0.3%	+152.5%	0.022%
8/14/2024	ProShare Advisors LLC	31,720	$0.71M	0.0%	-12.0%	0.010%
8/14/2024	Profund Advisors LLC	70,481	$1.58M	0.1%	-5.4%	0.023%
8/13/2024	Hancock Whitney Corp	42,818	$0.96M	0.0%	-11.2%	0.014%
8/13/2024	Ensign Peak Advisors Inc	484,356	$10.88M	0.0%	-5.7%	0.160%
8/13/2024	Thrivent Financial for Lutherans	79,051	$1.78M	0.0%	-62.2%	0.026%
8/13/2024	Sei Investments Co.	288,186	$6.48M	0.0%	-43.0%	0.095%
8/13/2024	Pacer Advisors Inc.	67,740	$1.52M	0.0%	+4.3%	0.022%
8/13/2024	Canada Pension Plan Investment Board	637,800	$14.33M	0.0%	+8.5%	0.210%
8/13/2024	Public Employees Retirement Association of Colorado	32,998	$0.74M	0.0%	-10.6%	0.011%
8/12/2024	Intech Investment Management LLC	156,552	$3.52M	0.0%	+56.5%	0.052%
8/12/2024	MQS Management LLC	11,542	$0.26M	0.2%	N/A	0.004%
8/12/2024	XTX Topco Ltd	13,748	$0.31M	0.0%	N/A	0.005%
8/12/2024	First Eagle Investment Management LLC	15,887	$0.36M	0.0%	+7.4%	0.005%
8/12/2024	Seven Eight Capital LP	96,404	$2.17M	0.2%	+27.4%	0.032%
8/12/2024	Hsbc Holdings PLC	90,211	$2.03M	0.0%	+45.3%	0.030%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $35.51

$34.97

$35.84

50 Day Range

MA: $27.48

$25.15

$34.77

52 Week Range

Now: $35.51

$19.20

$35.84

Volume

2,517,775 shs

Average Volume

2,075,560 shs

Market Capitalization

$10.14 billion

P/E Ratio

22.76

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
David Edward Johnson (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Peter Lamb (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Maria C Freire (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
Stephens Investment Management Group LLC — 1.33%
Los Angeles Capital Management LLC — 0.63%
Meditor Group Ltd — 0.45%
Assenagon Asset Management S.A. — 0.37%
Allspring Global Investments Holdings LLC — 0.28%
Principal Financial Group Inc. — 0.23%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Meditor Group Ltd
Principal Financial Group Inc.
Allspring Global Investments Holdings LLC
abrdn plc
Stephens Investment Management Group LLC
GSA Capital Partners LLP
Janney Montgomery Scott LLC
Within the previous year, company insiders that have sold Exelixis company stock include:
David Edward Johnson (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Peter Lamb (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
Los Angeles Capital Management LLC
Robeco Institutional Asset Management B.V.
Raymond James & Associates
Van ECK Associates Corp
DekaBank Deutsche Girozentrale
Friedenthal Financial
Capital Management Corp VA
CWA Asset Management Group LLC